Recommendations for phototherapy and photochemotherapy;Empfehlungen zur phototherapie und photochemotherapie

JDDG - Journal of the German Society of Dermatology

Volumn 1, Issue 12, 2003, Pages 985-997

  Holzle E ^a   Honigsmann H ^b   Rocken M ^b   Ghoreschi, K ^b   Lehmann, P ^b  

^a KLINIKUM OLDENBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BERGAPTEN; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; GERALEN; IMMUNOSUPPRESSIVE AGENT; MATRIX METALLOPROTEINASE; METHOTREXATE; METHOXSALEN; PSORALEN; RETINOID; TRIMETHYLPSORALEN; TRIPSOS; VITAMIN D DERIVATIVE;

APOPTOSIS; ATOPIC DERMATITIS; CONJUNCTIVITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATITIS; LENTIGO; LYMPHOMATOID PAPULOSIS; MELANOMA; MORPHEA; MYCOSIS FUNGOIDES; PARAPSORIASIS; PHOTOCHEMOTHERAPY; PHOTODERMATOSIS; PHOTOSENSITIVITY; PHOTOTHERAPY; PHOTOTOXICITY; PITYRIASIS LICHENOIDES; PRURIGO; PRURITUS; PSORIASIS VULGARIS; PUVA; RADIATION DOSE; REVIEW; RISK FACTOR; SEBORRHEIC DERMATITIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VITILIGO;

EID: 0346504094     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2003.03615.x     Document Type: Review

References (65)

1. Abeck D, Schmidt T, Fesq H. Long-term efficacy of medium dose UVA-1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-257.
2. Ables DJ, Kattan-Byron J. Psoriasis treatment at the Dead Sea: a natural selective ultraviolet phototherapy. J Am Acad Dermatol 1985; 12: 639-643.
3. British Photodermatology Group. British Photodermatology Group guidelines for PUVA. Br J Dermatol 1994; 130:246-255.
4. Cox NH, Jones SK, Downey DJ, et al. Cutaneous and ocular side-effects of oral photochemotherapy; results of an 8-year-follow-up study. Br J Dermatol 1987; 116: 145-152.
5. El Mofty AM. A preliminary report on the treatment of leukoderma with Ammi majus Linn. J R Egypt Med Assoc 1948; 31: 651-655.
6. Fisher T, Alsins J. Treatment of psoriasis with trioxalen baths and dysprosium lamps. Acta Derm Venereol 1974; 56: 383-390.
7. Fotiades J, Soter NA, Sanchez MR, Moy JA. A three-year follow-up evaluation on 28 HIV-positive patients treated with ultraviolet B (UVB) phototherapy. J Invest Dermatol 1995; 104: 660a.
8. Godar DE. UVA1 radiation mediates singlet-oxygen and superoxide-anion production which trigger two different final apoptotic pathways: the S and P site of mitochondria. J Invest Dermatol 1999; 112: 3-12.
9. Goeckermann WH. The treatment of psoriasis. Northwest Med 1925; 24: 229-231.
10. Grabbe J, Welker P, Humke S, Grewe M, Schöpf E, Henz BM, Krutmann J. Highdose UVA-1 therapy, but not UVA/UVB therapy, decreases IgE binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-423.
11. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparision of the efficacy and relapse rates of narrow-band UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127: 5-9.
12. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995; 104: 3-6.
13. Guidelines of care for phototherapy and photochemotherapy. American Academy of Dermatology Committee on Guidelines of Care. J Am Acad Dermatol 1994; 31: 643.
14. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E, Lindelöf B, Berne B, Hannuksela M, Poikolainen K, Karvonen J. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 1999; 141: 497-501.
15. Henseler T, Christophers E, Hönigsmann H, Wolff K. Skin tumors in the European PUVA study: eight year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 1987; 16: 108-116.
16. Henseler T, Wolff K, Hönigsmann H, Christopers E. The European PUVA study (EPS) on oral 8-methoxypsoralen photochemotherapy of psoriasis. A cooperative study among 18 European centres. Lancet 1981; 1: 853-857.
17. Herrmann Jr, Roenigk HH, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. I Am Acad Dermatol 1995; 33: 234-242.
18. Hofmann C, Plewig G, Braun-Falco O. Ungewöhnliche Nebenwirkungen bei oraler Photochemotherapie (PUVA-Therapie) der Psoriasis. Hautarzt: 1977; 28: 583-588.
19. Hölzle E, Hofmann C, Plewig G. PUVA-treatment for solar urticaria and persistent light reaction. Arch Dermatol Res 1980; 269: 87-91.
20. Hölzle E, Rowold J, Plewig G. Aktinische Prurigo. Hautarzt 1992; 43: 278-282.
21. Hönigsmann H, Fritsch P, Jaschke E. UV-Therapie der Psoriasis, Halbseitenvergleich zwischen oraler Photochemotherapie (PUVA) und selektiver UV-Phototherapie (SUP). Z Hautkr 1977; 52:1078-1082.
22. Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996; 135: 332.
23. Ibbotson SH, Farr PM. The time-course of proralen ultraviolet A (PUVA) erythema. J Invest Dermatol 1999; 113: 346-349.
24. Ingram JT. The approach to psoriasis. Br Med J 1953; II: 591-594.
25. Jaschke E, Hönigsmann H. Hydroa vacciniforme - Aktionsspektrum. UV-Toleranz nach Photochemotherapie. Hautarzt 1981; 32: 350-353.
26. Kerscher M, Lehmann P, Plewig G. Die PUVA-Bad-Therapie: Indikationen und praktische Durchführung. Hautarzt 1994; 45: 526-528.
27. Kerscher M, Plewig G, Lehmann P. PUVA-Bad Therapie mit 8-Methoxypsoralen zur Behandlung von palmoplantaren Dermatosen. H+G 1994; 69: 110-112.
28. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Röcken M. Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet 1994; i: 1233.
29. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Röcken M. PUVA-bath photochemotherapy of lichen planus. Arch Dermatol 1995; 131: 1210-1211.
30. Kobyletzki G, Pieck C, Hoffmann K, Freitag M, Altmeyer P. Medium-dose UVA-1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999; 41: 931-937.
31. Krutmann J. Dermatologische Phototherapie. Hautarzt 1991; 42: 407-414.
32. Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sönnichsen N, Czech W, Kapp A, Stege H, Grewe M, Schöpf E. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998; 38: 589-593.
33. Krutmann J, Hönigsmann H, Elmets CA, Bergstresser PR. Dermatological phototherapy and photodiagnostic methods. Springer, Berlin 2001.
34. Lowe NJ, Weingarten D, Moly LS. PUVA therapy for psoriasis: comparison of oral and bathwater delivery of 8-methoxypsoralen. J Am Dermatol 1986; 14: 754-760.
35. Mahrle G. Phototherapie in Kombination mit Cignolin, Teer und Retinoiden. In: Braun-Falco O, Schill WB (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie. Bd 11, Springer, Berlin, 1987; S 454.
36. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 2001; 358: 1042-1045.
37. Meola T, Soter NA, Ostreicher R, Sanchez M, Moy JA. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 1993; 29: 216-220.
38. Mutzhas MF, Hölzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol 1981; 76: 42-47.
39. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation. J Am Acad Dermatol 2000; 42: 245-253.
40. Ortel B, Tanew A, Wolff K, Hönigsmann H. Polymorphous light eruption: action spectrum and photoprotection. J Am Dermatol 1986; 14: 748-753.
41. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light. N Engl J Med 1974; 291: 1207-1211.
42. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
43. Pirkhammer D, Seeber A, Hönigsmann H, Tanew A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and save treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143: 964-968.
44. Plewig G, Hölzle E, Lehmann P. Phototherapy for photodermatoses. Curr Probl Dermatol 1986; 15: 254-264.
45. Reinauer S, Lehmann P, Plewig G, Heyll A, Söhngen D, Hölzle E. Photochemotherapie (PUVA) der akuten Graft-versus-Host-Erkrankung. Hautarzt 1993; 44: 708-712.
46. Röcken M, Kerscher M, Volkenandt M, Plewig G. Balneophorochemotherapie. Hautarzt 1995; 46: 437-450.
47. Rosenbaum MM, Roenigk HH, Caro WA, Esker A. Photochemotherapy in cutaneous T-cell lymphoma and parapsoriasis en plaque. J Am Acad Dermatol 1985; 13: 613-622.
48. Schmidt T, Abeck D, Boeck K, Mepel M, Ring J. UVA1 iradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol (Stockh) 1998; 78: 318-319.
49. Schwarz T, Rütter A, Hawk J. Phototherapy and photochemotherapy: less common indications for its use. In: Krutmann J, Hönigsmann H, Elmets CA, Bergstresser PR (eds) Dermatological phototherapy and photodiagnostic methods. Springer, Berlin, 2001; pp 179-197.
50. Stadler R, Otto HG, Luger T, Henz BM, Kuhl P, Zwingers T, Sterry W. Prosepctive randomized multicenter clinical traial on the use of interferon-2α plus acitretin versus interferon-2α plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998; 92: 3578-3581.
51. Stege H, Berneburg M, Humke S, Lammer M, Grewe M, Grether-Beck S, Dierks K, Hoerz G, Ruzicka T, Krutmann J. High-dose ultraviolet A1 (UVA1) radiation therapy for localized scleroderma. J Am Dermatol 1997; 36: 938-943.
52. Stege H, Berneburg M, Ruzicka T, Kurtmann J. Cream-PUVA-Photochemotherapy. Hautarzt 1997; 48: 89-93.
53. Sterenborg HCJM, van der Leun JC. Tumorigenesis by a long wavelength UV-A source. Photochem Photobiol 1990; 51: 325-330.
54. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-2764.
55. Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 1998; 90: 1278-1284.
56. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 1998; 134(12): 1582-1585.
57. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-1045.
58. Storbeck H, Hölzle E, Schürer N, Lehmann P, Plewig G. Narrow-band UVB (311 nm) versus conventional broadband UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227-231.
59. Streit V, Wiedow O, Christophers E. Innovative Balneotherapie mit reduzierten Badevolumina: Folienbäder. Hautarzt 1994; 45: 140-144.
60. Tzaneva S, Seeber A, Schwaiger M, Hönigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001;45:503-507.
61. Van de Kerkhof PCM, De Rooij MJM. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maimtenance. Br J Dermatol 1997; 136: 275-278.
62. Van Weelden H, De La Faille HB, Young E, Van der Leun IC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
63. Volc-Platzer B, Hönigsmann H, Hinterberger W, Wolff K. Photochemotherapy improves chronic cutaneous graft-versus-host disease. I Am Acad Dermatol 1990; 23: 220-228.
64. Wlascheck M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharffetter-Kochanek K. UVA-induced autocrine stimulation of fibroblasts derived collagenase/MMP1 by interrelated loops of interleukin-1 and interleukin-6. Photobiol 1994; 59: 550-556.
65. Yoo EK, Rook AH, Elenitas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-242.